10-103379720-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006951.5(TAF5):c.1226G>A(p.Ser409Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0073 in 1,606,738 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
Genomes: 𝑓 0.0042 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0076 ( 53 hom. )
Consequence
TAF5
NM_006951.5 missense
NM_006951.5 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 4.79
Genes affected
TAF5 (HGNC:11539): (TATA-box binding protein associated factor 5) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes an integral subunit of TFIID associated with all transcriptionally competent forms of that complex. This subunit interacts strongly with two TFIID subunits that show similarity to histones H3 and H4, and it may participate in forming a nucleosome-like core in the TFIID complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0035065114).
BS2
High AC in GnomAd4 at 646 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF5 | NM_006951.5 | c.1226G>A | p.Ser409Asn | missense_variant | 4/11 | ENST00000369839.4 | NP_008882.2 | |
TAF5 | NM_139052.3 | c.1226G>A | p.Ser409Asn | missense_variant | 4/10 | NP_620640.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF5 | ENST00000369839.4 | c.1226G>A | p.Ser409Asn | missense_variant | 4/11 | 1 | NM_006951.5 | ENSP00000358854 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00425 AC: 646AN: 152150Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
646
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00544 AC: 1328AN: 244248Hom.: 7 AF XY: 0.00627 AC XY: 827AN XY: 131958
GnomAD3 exomes
AF:
AC:
1328
AN:
244248
Hom.:
AF XY:
AC XY:
827
AN XY:
131958
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00762 AC: 11078AN: 1454470Hom.: 53 Cov.: 32 AF XY: 0.00776 AC XY: 5609AN XY: 723076
GnomAD4 exome
AF:
AC:
11078
AN:
1454470
Hom.:
Cov.:
32
AF XY:
AC XY:
5609
AN XY:
723076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00424 AC: 646AN: 152268Hom.: 2 Cov.: 32 AF XY: 0.00429 AC XY: 319AN XY: 74444
GnomAD4 genome
AF:
AC:
646
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
319
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
22
ALSPAC
AF:
AC:
37
ESP6500AA
AF:
AC:
8
ESP6500EA
AF:
AC:
65
ExAC
AF:
AC:
677
Asia WGS
AF:
AC:
26
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link
Submissions by phenotype
not provided Other:1
not provided, no classification provided | phenotyping only | GenomeConnect-Association for Creatine Deficiencies, Association for Creatine Deficiencies | - | Variant interpreted as Uncertain significance and reported on 06-08-2017 by GTR ID 1006. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect facilitates ClinVar submission from the Association for Creatine Deficiencies registry and does not attempt to reinterpret the variant. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at